ARGENX Trademark

Trademark Overview


On Monday, January 13, 2025, a trademark application was filed for ARGENX with the United States Patent and Trademark Office. The USPTO has given the ARGENX trademark a serial number of 98957449. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, January 13, 2025. This trademark is owned by Argenx B.V.. The ARGENX trademark is filed in the Advertising, Business and Retail Services, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceuticals and medical preparations for therapeutic purposes in the field of immunology and autoimmune diseases; pharmaceutical preparations for the prevention or treatment of autoimmune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, and transplantation-related diseases and disorders, cancer and diseases of the immune system; compositions of antibodies or fragments of antibodies or derivatives of antibodies with therapeutic properties; antibodies or fragments of antibodies or derivatives of antibodies for the prevention or treatment of autoimmune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, transplantation-related diseases and disorders, cancer and diseases of the immune system

Wholesale and retail services for therapeutic pharmaceutical preparations in the field of immunology and auto-immune diseases and antibodies or fragments or derivatives of antibodies with therapeutic properties; Administrative services in relation to patient information in the field of immunology, diseases of the immune system and antibody therapeutics; administration of patient reimbursement programs

Providing information to patients in the field of auto-immune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, and transplantation-related diseases and disorders, cancer and diseases of the immune system and the treatment thereof; consultancy and information services relating to therapeutic biopharmaceutical products; Provision of information on therapeutic pharmaceutical, medical, and healthcare products to customers or patients through an online computer network

Research and development in the field of immunology, antibody engineering and autoimmune diseases for therapeutic purposes; therapeutic drug research and development in the field of immunology, antibody technology and autoimmune diseases; scientific and technological services and research relating to immunity, autoimmune diseases and antibody engineering for therapeutic purposes; providing medical and scientific research information in the field of therapeutic pharmaceuticals, clinical trials, research and development
argenx

General Information


Serial Number98957449
Word MarkARGENX
Filing DateMonday, January 13, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateMonday, January 13, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


In Another Form StatementThe mark was first used anywhere in a different form other than that sought to be registered at least as early as 01/00/2008.
In Another Form StatementThe mark was first used in commerce in a different form other than that sought to be registered at least as early as 01/00/2008.
In Another Form StatementThe mark was first used anywhere in a different form other than that sought to be registered at least as early as 01/00/2008.
Goods and ServicesPharmaceuticals and medical preparations for therapeutic purposes in the field of immunology and autoimmune diseases; pharmaceutical preparations for the prevention or treatment of autoimmune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, and transplantation-related diseases and disorders, cancer and diseases of the immune system; compositions of antibodies or fragments of antibodies or derivatives of antibodies with therapeutic properties; antibodies or fragments of antibodies or derivatives of antibodies for the prevention or treatment of autoimmune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, transplantation-related diseases and disorders, cancer and diseases of the immune system
In Another Form StatementThe mark was first used in commerce in a different form other than that sought to be registered at least as early as 01/00/2008.
In Another Form StatementThe mark was first used in commerce in a different form other than that sought to be registered at least as early as 01/00/2008.
In Another Form StatementThe mark was first used anywhere in a different form other than that sought to be registered at least as early as 01/00/2008.
In Another Form StatementThe mark was first used anywhere in a different form other than that sought to be registered at least as early as 01/00/2008.
In Another Form StatementThe mark was first used in commerce in a different form other than that sought to be registered at least as early as 01/00/2008.
Goods and ServicesWholesale and retail services for therapeutic pharmaceutical preparations in the field of immunology and auto-immune diseases and antibodies or fragments or derivatives of antibodies with therapeutic properties; Administrative services in relation to patient information in the field of immunology, diseases of the immune system and antibody therapeutics; administration of patient reimbursement programs
Goods and ServicesProviding information to patients in the field of auto-immune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, and transplantation-related diseases and disorders, cancer and diseases of the immune system and the treatment thereof; consultancy and information services relating to therapeutic biopharmaceutical products; Provision of information on therapeutic pharmaceutical, medical, and healthcare products to customers or patients through an online computer network
Goods and ServicesResearch and development in the field of immunology, antibody engineering and autoimmune diseases for therapeutic purposes; therapeutic drug research and development in the field of immunology, antibody technology and autoimmune diseases; scientific and technological services and research relating to immunity, autoimmune diseases and antibody engineering for therapeutic purposes; providing medical and scientific research information in the field of therapeutic pharmaceuticals, clinical trials, research and development

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, January 13, 2025
Primary Code035
First Use Anywhere DateFriday, December 17, 2021
First Use In Commerce DateFriday, December 17, 2021

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 13, 2025
Primary Code005
First Use Anywhere DateFriday, December 17, 2021
First Use In Commerce DateFriday, December 17, 2021

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 13, 2025
Primary Code042
First Use Anywhere DateTuesday, November 10, 2015
First Use In Commerce DateTuesday, November 10, 2015

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 13, 2025
Primary Code044
First Use Anywhere DateMonday, June 1, 2020
First Use In Commerce DateMonday, June 1, 2020

Trademark Owner History


Party NameArgenx B.V.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressZwijnaarde B-9052
BE

Trademark Events


Event DateEvent Description
Monday, January 13, 2025NEW APPLICATION ENTERED